TABLE 2

Excretion of radioactivity in human urine and feces after a single oral dose of [14C]eltrombopag olamine

Collection Interval%Administered Dose in Subject
123456MeanS.D.
Urine
    0–12 h3.258.464.892.862.872.384.122.30
    12–24 h4.5113.88.085.975.698.377.743.32
    24–48 h7.6312.810.79.567.8115.610.73.08
    48–72 h3.834.225.053.653.473.443.940.61
    72–96 h2.092.632.071.601.631.761.960.39
    96–120 h1.381.701.201.290.850.461.150.43
    120–144 h0.731.000.430.650.520.360.620.23
    144–168 h0.440.780.440.410.530.250.480.18
    Subtotal23.945.432.926.023.432.630.78.32
Feces
    0–12 hN.S.N.S.N.S.N.S.N.S.N.S.0.000.00
    12–24 h0.06N.S.0.04N.S.0.02N.S.0.020.03
    24–48 hN.S.N.S.6.12N.S.15.934.99.4913.9
    48–72 h21.321.012.422.812.0N.S.14.98.69
    72–96 hN.S.N.S.17.327.824.2N.S.11.613.1
    96–120 h28.8N.S.14.0N.S.9.5823.912.712.0
    120–144 h9.7519.99.1211.06.13N.S.9.326.51
    144–168 hN.S.N.S.0.552.781.95N.S.0.881.20
    Subtotal59.940.959.564.469.858.858.99.74
Totala83.886.392.490.493.291.589.63.73
  • N.S., no sample obtained, considered zero for calculation of mean and S.D.

  • a The total recovery included the radioactivity recovered from toilet tissues (<0.1% of dose per subject).